Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This hospital-based cross-sectional study aims to determine the prevalence and serotype distribution of nasopharyngeal Streptococcus pneumoniae carriage among children aged 2-59 months hospitalized with acute respiratory symptoms at Vietnam National Children's Hospital (VNCH). Whole genome sequencing (WGS) will be used for serotype identification, antimicrobial resistance gene detection, and characterization of co-colonization patterns. The study will compare carriage prevalence and serotype distribution between previously healthy children and children with underlying comorbidities. Findings will inform pneumococcal vaccine policy and antimicrobial resistance surveillance in Vietnam.
Nasopharyngeal colonization with Streptococcus pneumoniae is a prerequisite for invasive pneumococcal disease. In Vietnam, PCV10 and PCV13 have been introduced in the private sector; however, updated surveillance data reflecting post-vaccine serotype dynamics are limited.
This study will enroll 530 children aged 2 months to 59 months hospitalized with acute respiratory symptoms. Participants will be categorized into:
The study will evaluate associations between pneumococcal carriage and demographic, clinical, vaccination, and environmental factors.
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Prevalence of Pneumococcal Carriage | Proportion of participants with S. pneumoniae detected from nasopharyngeal swab Analysis: Prevalence with 95% confidence intervals | At enrollment |
| Pneumococcal Serotype Distribution | Frequency distribution of pneumococcal serotypes identified via Whole Genome Sequencing | At enrollment |
| Measure | Description | Time Frame |
|---|---|---|
| Antimicrobial Resistance Genes | Presence of resistance genes (e.g., ermB, mefA, pbp variants) | at enrollment |
| Vaccine Serotype Coverage | Proportion of identified serotypes covered by PCV10, PCV13, PCV15, PCV20 |
Not provided
Inclusion Criteria:
Acute respiratory symptoms defined as one or more of:
Exclusion Criteria:
Not provided
Not provided
Children aged 2 months to 59 months hospitalized at Vietnam National Children's Hospital with acute respiratory symptoms
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Vietnam National Children's Hospital | Hanoi | 00000 | Vietnam |
IPD might be shared with relevant request and upon approval by local regulatory body
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Feb 15, 2026 | Apr 25, 2026 | Prot_SAP_000.pdf |
Not provided
Not provided
Not provided
Not provided
Sample Type: Nasopharyngeal swab Analysis: Culture, MALDI-TOF identification, Whole genome sequencing, Resistance gene analysis
| At enrollment |